Axel Svedbom

Publications
CV
Public outreach and news

Articles

Article: JAMA NETWORK OPEN. 2024;7(2):e240407
Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
Article: CLINICAL EPIDEMIOLOGY. 2024;16:213-225
Microscopic Colitis and Risk of Incident Psoriasis : A Nationwide Population-Based Matched Cohort Study
Bergman D; Roelstraete B; Sun J; Ebrahimi F; Lidstroem R; Svedbom A; Stahle M; Ludvigsson JF
Article: ADVANCES IN THERAPY. 2023;40(10):4657-4674
Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication.
Dalén J; Svedbom A; Hernlund E; Olofsson T; Black CM
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023;37(9):1841-1847
The psoriasis area and severity index is an independent risk factor for cardiovascular events: A prospective register study
Svedbom A; Stahle M
Article: ACTA DERMATO-VENEREOLOGICA. 2023;103:adv7312
Establishment and Utility of SwedAD: A Nationwide Swedish Registry for Patients with Atopic Dermatitis Receiving Systemic Pharmacotherapy
Alsterholm M; Svedbom A; Anderson CD; Holm Sommar L; Ivert LU; Josefson A; von Kobyletzki L; Lindberg M; Lundeberg L; Lundqvist M; Nylander E; Sandstrom Falk M; Shayesteh A; Sigurdardottir G; Sonesson A; Svensson A; Virtanen M; Vrang S; Wahlgren C-F; Bradley M; Johansson EK
Article: QUALITY OF LIFE RESEARCH. 2023;32(4):1199-1208
An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROS
Svedbom A; Borgstom F; Hernlund E; Alekna V; Bianchi ML; Clark P; Diaz-Curiel M; Dimai HP; Jurisson M; Lesnyak O; McCloskey E; Sanders KM; Silverman S; Tamulaitiene M; Thomas T; Tosteson ANA; Jonsson B; Kanis JA
Article: ACTA DERMATO-VENEREOLOGICA. 2022;102:adv00801
The Impact of Systemic Treatment of Atopic Dermatitis on Depressive Symptoms: A Prospective Clinical Cohort Study
Ivert LU; Svedbom A; Lundqvist M; Wahlgren C-F; Bradley M; Johansson EK
Article: OSTEOPOROSIS INTERNATIONAL. 2022;33(9):1895-1907
A micro-costing analysis of post-fracture care pathways: results from the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)
Talevski J; Sanders KM; Lal A; Watts JJ; Beauchamp A; Duque G; Borgstrom F; Kanis JA; Svedbom A; Brennan-Olsen SL
Article: ADVANCES IN THERAPY. 2022;39(6):2468-2486
Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study.
Dalén J; Chitkara A; Svedbom A; Olofsson T; Puenpatom A; Black CM; Qureshi ZP
Article: OSTEOPOROSIS INTERNATIONAL. 2022;33(3):625-635
Costs of patient management over 18 months following a hip, clinical vertebral, distal forearm, or proximal humerus fragility fracture in France-results from the ICUROS study
Coassy A; Svedbom A; Locrelle H; Chapurlat R; Cortet B; Fardellone P; Orcel P; Roux C; Borgstrom F; Kanis JA; Thomas T
Article: ADVANCES IN THERAPY. 2022;39(1):244-255
Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study.
Dalén J; Puenpatom A; Luttropp K; Svedbom A; Black CM
Article: OSTEOPOROSIS INTERNATIONAL. 2022;33(1):97-104
Thirty years of hip fracture incidence in Austria: is the worst over?
Dimai HP; Reichardt B; Zitt E; Concin H; Malle O; Fahrleitner-Pammer A; Svedbom A; Brozek W
Article: ARCHIVES OF OSTEOPOROSIS. 2021;16(1):112
Recovery of quality of life is associated with lower mortality 5-year post-fracture: the Australian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (AusICUROS)
Talevski J; Sanders KM; Vogrin S; Duque G; Beauchamp A; Seeman E; Iuliano S; Svedbom A; Borgstrom F; Kanis JA; Stuart AL; Brennan-Olsen SL
Article: JAMA DERMATOLOGY. 2021;157(6):1-8
Long-term Outcomes and Prognosis in New-Onset Psoriasis
Svedbom A; Mallbris L; Larsson P; Nikamo P; Wolk K; Kjellman P; Sonkoly E; Eidsmo L; Lindqvist U; Stahle M
Article: BONE. 2021;144:115805
Health service use pathways associated with recovery of quality of life at 12-months for individual fracture sites: Analyses of the International Costs and Utilities Related to Osteoporotic fractures Study (ICUROS)
Talevski J; Sanders KM; Busija L; Beauchamp A; Duque G; Borgstrom F; Kanis JA; Svedbom A; Stuart AL; Brennan-Olsen S
Article: BONE. 2021;142:115071
Mind the gap: Incidence of osteoporosis treatment after an osteoporotic fracture - results of the Austrian branch of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)
Malle O; Borgstroem F; Fahrleitner-Pammer A; Svedbom A; Dimai SV; Dimai HP
Article: JOURNAL OF BONE AND MINERAL RESEARCH. 2020;36(2):252-261
Health Service Use and Quality of Life Recovery 12 Months Following Major Osteoporotic Fracture: Latent Class Analyses of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)
Talevski J; Sanders KM; Busija L; Beauchamp A; Duque G; Borgstrom F; Kanis JA; Svedbom A; Connaughton C; Stuart AL; Brennan-Olsen SL
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2020;34(6):1248-1256
Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis
Pasquali L; Svedbom A; Srivastava A; Rosen E; Lindqvist U; Stahle M; Pivarcsi A; Sonkoly E
Article: ARCHIVES OF OSTEOPOROSIS. 2020;15(1):37
Quality of life after fragility fracture in the Russian Federation: results from the Russian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (ICUROS)
Lesnyak O; Svedbom A; Belova K; Dobrovolskaya O; Ershova O; Golubev G; Grebenshikov V; Ivanov S; Kochish A; Menshikova L; Nikitinskaya O; Nurligayanov R; Solodovnikov A; Toroptsova N; Varavko J; Zotkin E; Borgstrom F; Kanis JA
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2020;34(3):525-532
Real-world comparative effectiveness of adalimumab, etanercept and methotrexate: a Swedish register analysis
Svedbom A; Stahle M
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2019;26(4):603-609
Clinical course of multiple sclerosis and labour-force absenteeism: a longitudinal population-based study
Castelo-Branco A; Landfeldt E; Svedbom A; Lofroth E; Kavaliunas A; Hillert J
Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2018;24:145-150
The long-term impact of multiple sclerosis on the risk of divorce
Landfeldt E; Castelo-Branco A; Svedbom A; Lofroth E; Kavaliunas A; Hillert J
Article: VALUE IN HEALTH. 2018;21(5):590-595
Personal Income Before and After Diagnosis of Multiple Sclerosis
Landfeldt E; Castelo-Branco A; Svedbom A; Lofroth E; Kavaliunas A; Hillert J
Article: OSTEOPOROSIS INTERNATIONAL. 2018;29(5):1147-1154
Health-related quality of life during the first year after a hip fracture: results of the Mexican arm of the International Cost and Utility Related to Osteoporotic Fractures Study (MexICUROS)
Guirant L; Carlos F; Curiel D; Kanis JA; Borgstrom F; Svedbom A; Clark P
Article: JOURNAL OF NEUROLOGY. 2018;265(3):701-707
The long-term impact of early treatment of multiple sclerosis on the risk of disability pension
Landfeldt E; Castelo-Branco A; Svedbom A; Lofroth E; Kavaliunas A; Hillert J
Article: QUALITY OF LIFE RESEARCH. 2018;27(3):707-716
Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS
Svedbom A; Borgstrom F; Hernlund E; Strom O; Alekna V; Bianchi ML; Clark P; Curiel MD; Dimai HP; Jurisson M; Uuskula A; Lember M; Kallikorm R; Lesnyak O; McCloskey E; Ershova O; Sanders KM; Silverman S; Tamulaitiene M; Thomas T; Tosteson ANA; Jonsson B; Kanis JA
Article: OSTEOPOROSIS INTERNATIONAL. 2018;29(3):557-566
Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS
Svedbom A; Borgstom F; Hernlund E; Strom O; Alekna V; Bianchi ML; Clark P; Curiel MD; Dimai HP; Jurisson M; Kallikorm R; Lember M; Lesnyak O; McCloskey E; Sanders KM; Silverman S; Solodovnikov A; Tamulaitiene M; Thomas T; Toroptsova N; Uuskula A; Tosteson ANA; Jonsson B; Kanis JA
Article: CLINICOECONOMICS AND OUTCOMES RESEARCH. 2018;10:747-759
Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain.
Johansson E; Nuñez M; Svedbom A; Dilla T; Hartz S
Article: PATIENT PREFERENCE AND ADHERENCE. 2017;11:95-106
Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line.
Svedbom A; Dalén J; Black CM; Kachroo S
Article: MULTIPLE SCLEROSIS JOURNAL. 2016;22(14):1859-1866
Sick leave and disability pension before and after diagnosis of multiple sclerosis
Landfeldt E; Castelo-Branco A; Svedbom A; Lofroth E; Kavaliunas A; Hillert J
Article: OSTEOPOROSIS INTERNATIONAL. 2016;27(8):2555-2566
Quality of life, resource use, and costs related to hip fracture in Estonia
Jurisson M; Pisarev H; Kanis J; Borgstrom F; Svedbom A; Kallikorm R; Lember M; Uuskula A
Article: RHEUMATOLOGY INTERNATIONAL. 2016;36(7):987-995
Treatment persistence among patients with immune-mediated rheumatic disease newly treated with subcutaneous TNF-alpha inhibitors and costs associated with non-persistence
Dalen J; Svedbom A; Black CM; Lyu R; Ding Q; Sajjan S; Sazonov V; Kachroo S
Article: ACTA DERMATO-VENEREOLOGICA. 2016;96(5):651-657
Economic Burden of Psoriasis and Potential Cost Offsets with Biologic Treatment: A Swedish Register Analysis
Svedbom A; Dalen J; Mamolo C; Cappelleri JC; Mallbris L; Petersson IF; Stahle M
Article: CURRENT MEDICAL RESEARCH AND OPINION. 2015;31(11):2145-2156
Is dibotermin alfa a cost-effective substitute for autologous iliac crest bone graft in single level lumbar interbody spine fusion?
Svedbom A; Paech D; Leonard C; Donnell D; Song F; Boszcyk B; Rothenfluh DA; Lloyd A; Borgman B
Article: ACTA DERMATO-VENEREOLOGICA. 2015;95(7):809-815
Increased Cause-specific Mortality in Patients with Mild and Severe Psoriasis: A Population-based Swedish Register Study
Svedbom A; Dalen J; Mamolo C; Cappelleri JC; Mallbris L; Petersson IF; Stahle M
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2015;29(2):215-223
Treatment patterns with topicals, traditional systemics and biologics in psoriasis - a Swedish database analysis
Svedbom A; Dalen J; Mamolo C; Cappelleri JC; Petersson IF; Stahle M
Article: OSTEOPOROSIS INTERNATIONAL. 2014;25(9):2297-2306
Epidemiology of distal forearm fractures in Austria between 1989 and 2010.
Dimai HP; Svedbom A; Fahrleitner-Pammer A; Resch H; Muschitz C; Thaler H; Szivak M; Amrein K; Borgström F
Article: OSTEOPOROSIS INTERNATIONAL. 2014;25(1):325-337
Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm
Kim K; Svedbom A; Luo X; Sutradhar S; Kanis JA
Article: OSTEOPOROSIS INTERNATIONAL. 2013;24(9):2413-2421
Epidemiology of proximal humeral fractures in Austria between 1989 and 2008
Dimai HP; Svedbom A; Fahrleitner-Pammer A; Pieber T; Resch H; Zwettler E; Thaler H; Szivak M; Amrein K; Borgstrom F
Article: OSTEOPOROSIS INTERNATIONAL. 2013;24(3):811-823
The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)-quality of life during the first 4 months after fracture
Borgstrom F; Lekander I; Ivergard M; Strom O; Svedbom A; Alekna V; Bianchi ML; Clark P; Curiel MD; Dimai HP; Jurisson M; Kallikorm R; Lesnyak O; McCloskey E; Nassonov E; Sanders KM; Silverman S; Tamulaitiene M; Thomas T; Tosteson ANA; Jonsson B; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1):137
Osteoporosis in the European Union: a compendium of country-specific reports.
Svedbom A; Hernlund E; Ivergård M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jönsson B; Kanis JA; EU Review Panel of IOF
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1):136
Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
Hernlund E; Svedbom A; Ivergård M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jönsson B; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in the Czech Republic
Svedbom A; Hernlund E; Ivergard M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Bayer M; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Austria A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)
Svedbom A; Hernlund E; Ivergard M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Dimai HP; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Italy
Svedbom A; Hernlund E; Ivergard M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Brandi ML; Silveri F; Rossini M; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Ireland
Svedbom A; Hernlund E; Ivergard M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; O'Brien M; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Hungary
Svedbom A; Hernlund E; Ivergard M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Lakatos P; Szekeres L; Marton I; Zalatnai K; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Greece
Svedbom A; Hernlund E; Ivergard M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Lyritis GP; Makras P; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Germany
Svedbom A; Hernlund E; Ivergard M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Dreinhoefer K; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in France
Svedbom A; Hernlund E; Ivergard M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Finland
Svedbom A; Hernlund E; Ivergard M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Kroger H; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Estonia
Svedbom A; Hernlund E; Ivergard M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Maasalu K; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Denmark
Svedbom A; Hernlund E; Ivergard M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Abrahamsen B; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Cyprus
Svedbom A; Hernlund E; Ivergard M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Georgiades GL; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Bulgaria
Svedbom A; Hernlund E; Ivergard M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Borissova A-M; Kovacheva R; Shinkov A; Boyanov M; Rachkov R; Popivanov P; Kolarov Z; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in UK
Ivergard M; Svedbom A; Hernlund E; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Sweden
Ivergard M; Svedbom A; Hernlund E; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Akesson K; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Spain
Ivergard M; Svedbom A; Hernlund E; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Diez-Perez A; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Slovenia
Ivergard M; Svedbom A; Hernlund E; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Kocjan T; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Slovakia
Ivergard M; Svedbom A; Hernlund E; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Masaryk P; Payer J; Jackuliak P; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Romania
Ivergard M; Svedbom A; Hernlund E; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Grigorie D; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Portugal
Ivergard M; Svedbom A; Hernlund E; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Monteiro J; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Poland
Ivergard M; Svedbom A; Hernlund E; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Czerwinski E; Badurski JE; Lorene RS; Jaworski M; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in the Netherlands
Ivergard M; Svedbom A; Hernlund E; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Papapoulos S; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Malta
Ivergard M; Svedbom A; Hernlund E; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Galea RP; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Luxembourg
Ivergard M; Svedbom A; Hernlund E; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Hirsch M; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Lithuania
Ivergard M; Svedbom A; Hernlund E; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Alekna V; Tamulaitiene M; Kanis JA
Article: ARCHIVES OF OSTEOPOROSIS. 2013;8(1-2)
Epidemiology and Economic Burden of Osteoporosis in Latvia
Ivergard M; Svedbom A; Hernlund E; Compston J; Cooper C; Stenmark J; McCloskey EV; Jonsson B; Rasa I; Pavlina I; Berza S; Kanis JA
Article: OSTEOPOROSIS INTERNATIONAL. 2013;24(1):355-367
Balloon kyphoplasty compared to vertebroplasty and nonsurgical management in patients hospitalised with acute osteoporotic vertebral compression fracture: a UK cost-effectiveness analysis
Svedbom A; Alvares L; Cooper C; Marsh D; Strom O
Article: OSTEOPOROSIS INTERNATIONAL. 2011;22(2):685-692
Epidemiology of hip fractures in Austria: evidence for a change in the secular trend
Dimai HP; Svedbom A; Fahrleitner-Pammer A; Pieber T; Resch H; Zwettler E; Chandran M; Borgstrom F
Show more

All other publications

Letter: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2023;143(12):2529-2532.e1
Itch Is More Important than Clinical Disease Severity for Depression in Psoriasis: A Prospective Register Study
Svedbom A; Stahle M
Editorial comment: ACTA DERMATO-VENEREOLOGICA. 2023;103:adv7138
Interleukin-17 and-23 Inhibitors Associated with Direct Effects on Depressive Symptoms in Psoriasis: A Register Study
Svedbom A; Stahle M
Letter: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2022;87(6):1438-1440
Type 1 and type 2 psoriasis revisited: No association between age at onset and disease course
Svedbom A; Stahle M
Corrigendum: ADVANCES IN THERAPY. 2022;39(6):2487-2488
Correction to: Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study.
Dalén J; Chitkara A; Svedbom A; Olofsson T; Puenpatom A; Black CM; Qureshi ZP
Corrigendum: ADVANCES IN THERAPY. 2022;39(1):256
Correction to: Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study.
Dalén J; Puenpatom A; Luttropp K; Svedbom A; Black CM
Letter: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2021;85(4):1013-1015
Risk of respiratory infection in patients with plaque psoriasis
Svedbom A; Mallbris L; Stahle M
Thesis / dissertation: 2021
Psoriasis : observational studies on clinical course, economic burden and treatment
Svedbom, Axel
Letter: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2020;140(8):1653-1656.e1
Interaction between Smoking and HLA-C*06:02 on the Response to Ustekinumab in Psoriasis
Svedbom A; Nikamo P; Stahle M
Review: PATIENT PREFERENCE AND ADHERENCE. 2020;14:309-320
Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis - A Systematic Literature Review.
Luttropp K; Dalén J; Svedbom A; Dozier M; Black CM; Puenpatom A
Review: PATIENT PREFERENCE AND ADHERENCE. 2017;11:719-729
Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis.
Svedbom A; Storck C; Kachroo S; Govoni M; Khalifa A
Editorial comment: JOURNAL OF BONE AND MINERAL RESEARCH. 2014;29(9):1926-1928
The Osteoporosis Treatment Gap
Kanis JA; Svedbom A; Harvey N; McCloskey EV
Editorial comment: ACTA ENDOCRINOLOGICA-BUCHAREST. 2013;9(4):509-514
THE OSTEOPOROSIS TREATMENT GAP IN ROMANIA
Kanis JA; Hernlund E; Svedbom A; Ivergard M; Grigorie D

Employments

Postdoctoral Researcher, Department of Medicine, Karolinska Institutet, 2023-2025

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2021

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI